Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and...

56
Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity [email protected] 225-4054

Transcript of Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and...

Page 1: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Introduction to DNA Microarrays

Michael F. Miles, M.D., Ph.D.

Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of

Biological Complexity

[email protected]

225-4054

Page 2: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Biological Regulation: “You are what you express”

• Levels of regulation

• Methods of measurement

• Concept of genomics

Page 3: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Regulation of Gene Expression

• Transcriptional– Altered DNA binding protein complex abundance or function

• Post-transcriptional– mRNA stability– mRNA processing (alternative splicing)

• Translational– RNA trafficking– RNA binding proteins

• Post-translational– Many forms!

Page 4: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Regulation of Gene Expression

• Genes are expressed when they are transcribed into RNA

• Amount of mRNA indicates gene activity

• Some genes expressed in all tissues -- but are still

regulated!

• Some genes expressed selectively depending on tissue,

disease, environment

• Dynamic regulation of gene expression allows long term

responses to environment

Page 5: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Acute Drug Use

Mesolimbic dopamine? Other

ReinforcementIntoxication

Chronic Drug Use

Compulsive Drug Use

“Addiction”

?Synaptic RemodelingPersistent Gene Exp.

ToleranceDependence

Sensitization

Altered SignalingGene Expression

?Synaptic Remodeling

Page 6: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Progress in Studies on Gene Regulation

1960 1970 1980 1990 2000

mRNA,tRNA discovered

Nucleic acid hybridization, protein/RNA electrophoresis

Molecular cloning; Southern, Northern & Western blots; 2-D gels

Subtractive Hybridization, PCR, Differential Display,

MALDI/TOF MS

Genome Sequencing

DNA/Protein Microarrays

Page 7: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Nucleic Acid Hybridization: How It Works

Page 8: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Primer on Nucleic Acid Hybridization

• Hybridization rate depends on time,the concentration of nucleic acids, and the reassociation constant for the nucleic acid:

C/Co = 1/(1+kCot)

Page 9: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

High Density DNA Microarrays

Page 10: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

A Bit of History

~1992-1996: Oligo arrays developed by Fodor, Stryer, Lockhart, others at Stanford/Affymetrix and Southern in Great Britain

~1994-1995: cDNA arrays usually attributed to Pat Brown and Dari Shalon at Stanford who first used a robot to print the arrays. In 1994, Shalon started Synteni which was bought by Incyte in 1998.

However, in 1982 Augenlicht and Korbin proposed a DNA array (Cancer Research) and in 1984 they made a 4000 element array to interrogate human cancer cells.

(Rejected by Science, Nature and the NIH)

Page 11: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Biological Networks

Page 12: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Types of Biological Networks

Page 13: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Gene Regulation Network

Page 14: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Examining Biological Networks: Experimental Design

Page 15: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Examining Biological Networks

Page 16: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

PFCHIP VTA

NAC

Use of S-score in Hierarchical Clustering of Brain Regional Expression Patterns

0 +2-2

relative change

PFCHIP NAC

VTA

AvgDiff S-score

Page 17: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Expression Profiling: A Non-biased, Genomic Approach to Resolving the Mechanisms of Addiction

Candidate Gene Studies

Cycles of Expression

Profiling

Merge with Biological Databases

Page 18: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Utility of Expression Profiling

• Non-biased, genome-wide

• Hypothesis generating

• Gene hunting

• Pattern identification: – Insight into gene function– Molecular classification– Phenotypic mechanisms

Page 19: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Hybridization and Scanning

GE Database (SQL Server)

Comparisons(S-score, d-

chip)

Clustering Techniques

Statistical Filtering

(e.g. SAM)

Overlay Biological Databases(PubGen,

GenMAPP, QTL, etc.)

Provisional Gene

“Patterns”

Filtered Gene Lists

Candidate Genes

Molecular Validation

(RT-PCR, in situ, Western)

Behavioral Validation

De-noise

Experimental Design

Page 20: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Experimental Design with DNA Microarrays

Page 21: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

High Density DNA Microarrays

Page 22: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Synthesis and Analysis of 2-color Spotted cDNA Arrays: “Brown Chips”

Page 23: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 24: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Comparative Hybridization with Spotted cDNA Microarrays

Page 25: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Synthesis of High Density Oligonucleotide Arrays by Photolithography/Photochemistry

Page 26: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

GeneChip Features

• Parallel analysis of >30K human, rat or mouse genes/EST clusters with 15-20 oligos (25 mer) per gene/EST

• entire genome analysis (human, yeast, mouse)

• 3-4 orders of magnitude dynamic range (1-10,000 copies/cell)

• quantitative for changes >25% ??

• SNP analysis

Page 27: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Oligonucleotide Array Analysis

AAAA

Oligo(dT)-T7

Total RNA Rtase/Pol II

dsDNAAAAA-T7TTTT-T7

CTP-biotin

T7 polTTTT-5’5’

Biotin-cRNA

Hybridization

Steptavidin-phycoerythrin

Scanning

PM

MM

Page 28: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Stepwise Analysis of Microarray Data

• Low-level analysis -- image analysis, expression quantitation

• Primary analysis -- is there a change in expression?

• Secondary analysis -- what genes show correlated patterns of expression? (supervised vs. unsupervised)

• Tertiary analysis -- is there a phenotypic “trace” for a given expression pattern?

Page 29: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Affymetrix Arrays: Image Analysis

Page 30: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Affymetrix Arrays: Image Analysis

“.DAT” file “.CEL” file

Page 31: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Affymetrix Arrays: PM-MM Difference Calculation

Probe pairs control for non-specific hybridization of oligonucleotides

Page 32: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Variability and Error in DNA Microarray Hybridizations

Page 33: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

(a)

Variability in Ln(FC)

- 4

- 3

- 2

- 1

0

1

2

3

4

- 4 - 3 - 2 - 1 0 1 2 3 4

l n ( P F C 1 A S / V T A 1 A S )

R = 0 . 7 1

ln(FoldChange) S-score

Ln(FC1)

Ln(FC2)

Page 34: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 35: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

• Position Dependent Nearest Neighbor (PDNN) - 2003Zhang, Miles and Aldape, (2003) A model of molecular interactions on short oligogonucleotide microarrays: implications for probe design and data analysis. Nature Biotech. In Press.

Page 36: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 37: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Chip Normalization Procedures

• Whole chip intensity– Assumes relatively few changes, uniform

error/noise across chip and abundance classes

• Spiked standards– Requires exquisite technical control, assumes

uniform behavior

• Internal Standards– Assumes no significant regulation

• “Piece-wise” linear normalization

Page 38: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Normalization Confounds: Non-uniform Chip Behavior

S-s

core

Gene

Page 39: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Normalization Confounds: Non-linearity

Page 40: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

“Lowess” normalization,Pin-specific Profiles

After Print-tip Normalization

Slide Normalization: Pieces and Pins

See also: Schuchhardt, J. et al., NAR 28: e47 (2000)

http://www.ipam.ucla.edu/publications/fg2000/fgt_tspeed9.pdf

Page 41: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Quality Assessment

• Gene specific: R/G correlation, %BG, %spot

• Array specific: normalization factor, % genes present, linearity, control/spike performance (e.g. 5’/3’ ratio, intensity)

• Across arrays: linearity, correlation, background, normalization factors, noise

Page 42: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Statistical Analysis of Microarrays: “Not Your Father’s Oldsmobile”

Page 43: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Normal vs. NormalNormal vs. Normal

Page 44: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Normal vs. TumorNormal vs. Tumor

Page 45: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Sources of Variability

• Target Preparation– Group target preps

• Chip Run– Minor, BUT…– Be aware of processing order

• Chip Lot– Stagger lots across experiment if necessary

• Chip Scanning Order– Cross and block chip scanning order

Page 46: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Secondary Analysis: Expression Patterns

• Supervised multivariate analyses– Support vector machines

• Non-supervised clustering methods– Hierarchical– K-means– SOM

Page 47: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

PFCHIP VTA

NAC

Use of S-score in Hierarchical Clustering of Brain Regional Expression Patterns

0 +2-2

relative change

PFCHIP NAC

VTA

AvgDiff

S-score

Page 48: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Expression Networks

Expression Profiling

Behavior

Pharmacology Genetics

Prot-Prot

Interactions

OntologyHomoloGen

e

BioMed Lit

Relations

Page 49: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Array Analysis: Conclusions

• Be careful! Assess quality control parameters rigorously

• Single arrays or experiments are of limited value

• Normalization and weighting for noise are critical procedures

• Across investigator/platform/species comparisons will most easily be done with relative data

Page 50: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 51: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 52: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 53: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 54: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Comparison of Primary Analysis Algorithms II

Page 55: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.
Page 56: Introduction to DNA Microarrays Michael F. Miles, M.D., Ph.D. Depts. of Pharmacology/Toxicology and Neurology and the Center for Study of Biological Complexity.

Spotted cDNA Microarrays